Search

everythinglearnresearchcommunity

for

Search:↓

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Understanding chaos and control mechanisms in disease can improve diagnosis and prediction in medicine.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Gastric exclusion surgery caused major weight loss and health improvements but led to some anemia and vitamin deficiencies.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Intense exercise at night can delay the body's internal clock gene expression by 2 to 4 hours.

Both genetic and lifestyle factors significantly affect female hair loss.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document explains various skin conditions in cats and how to diagnose and treat them.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Young women with PCOS without additional risk factors may have normal heart function.

Stem cells from umbilical cord blood may prevent hair loss caused by certain medications.